GRALISE ER 300 MG TABLET

gabapentin
$10.1981per EA
High Outlier

Strength

300 mg/1

NDC

52427080390

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

GABAPENTIN

Approval Type

New Drug (NDA)

FDA Application

NDA022544

On Market Since

10/1/2020

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

-0.2%

6M

-0.1%

1Y

-0.4%

3Y

+0.0%

5Y

+11.3%

All

+14.6%